Intravesical administration of 5-aminolevulinic acid (5-ALA): Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX

European Journal of Clinical Pharmacology

Volumn 56, Issue 3, 2000, Pages 241-246

  Popken, G ^a,b   Schultze Seemann, W ^a   Seiler, K U ^b   Birkel, M ^b   Wetterauer, U ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Arbeitskreis Klinische A   (Germany)

Author keywords

Bladder cancer; Fluorescent photodetection; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AMINOLEVULINIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTOPORPHYRINS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0033944678     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000151     Document Type: Article

References (28)

1. 1. Au JL, Dalton JT, Wientjes MG (1991) Evidence of significant absorption of sodium salicylate from urinary bladder of rats. J Pharmacol Exp Ther 258: 357-364
2. 2. Baumgartner R, Fuchs N, Jocham D, Stepp H, Unsold E (1992) Pharmacokinetics of fluorescent polyporphyrin Photofrin II in normal rat tissue and rat bladder tumor. Photochem Photobiol 55: 569-574
3. 3. Bermudez Moretti M, Correa Garcia SR, Chianelli MS, Ramos EH, Mattoon JR, Batlle A (1995) Evidence that 4-aminobutyric acid and 5-aminolevulinic acid share a common transport system into Saccharomyces cerevisiae. Int J Biochem Cell Biol 27: 169-73
4. 4. Cutler SJ, Heney NM, Friedell GH (1982) Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bonney WW, Proud R (eds) Bladder cancer, AUA monographs, vol. 1. Williams and Williams, Baltimore, pp 35
5. 5. Dalton JT, Weintjes MG, Au JL (1994) Effects of bladder resorption on pharmacokinetic data analysis. J Pharmacokinet Biopharm 22: 183-205
6. 6. del Batlle C (1993) Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B 20: 5-22
7. 7. Doss M (1979) Normal ranges of porphyrins and precursors in human tissue, urine and feces. In: Strik J, Koeman JH (eds) Chemical porphyrias in man. Elsevier, Amserdam, pp 221
8. 8. El-Sharabasy MM, Hegazy AA, el-Soubky MS, el-Maksoud MA (1990) Porphyrins and nucleic acid in some photosensitive skin diseases. Acta Med Hung 47: 99-106
9. 9. Gao X, Au JL, Badalament RA, Wientjes MG (1998) Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Clin Cancer Res 4: 139-143
10. 10. Gorschein A, Webber R (1987) d-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects. Clin Sci 72: 103-112
11. 11. Hohlbrugger G (1995) The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control. J Urol 154: 6-15
12. 12. Jezernik K, Pipan N (1993) Blood-urine barrier formation in mouse urinary bladder development. Anat Rec 235: 533-538
13. 13. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnieres G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ (1997) Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20: 402-408
14. 14. Jichlinski P, Wagnieres G, Forrer M, Mizeret J, Guillou L, Schmidlin F, Graber P, Van den Bergh H, Leisinger HJ (1997) The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder. Ann Urol (Paris) 31: 43-48
15. 15. Kajimwara M, Hara K, Takatori K, Matsumotot K (1993) Revised structure of a delta-aminolevulinic acid derivate. Clin Chem 39: 1867-1871
16. 16. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM (1993) Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150: 60-64
17. 17. Kondo M, Hirota N, Takaoka T, Kajiwara M (1993) Hemebiosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9: 95
18. 18. Kriegmair M, Baumgartner R, Knuechel R, Steinbach P, Ehsan A, Lumper W, Hofstadter F, Hofstetter A (1994) Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44: 836-841
19. 19. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155: 105-109
20. 20. Kriegmair M, Baumgartner R, Lumper W, Waidelich R, Hofstetter A (1996) Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 77: 667-671
21. 21. Miyajima K, Hirata M, Yoshida T, Kosaka H, Okayama O (1994) Study on measurement of delta-aminolevulinic acid in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 645: 165-169
22. 22. Morita Y, Araki T, Sakai T, Araki T, Masuyama Y (1994) Determination of delta-aminolevulinic acid in plasma using high performance liquid chromatography: a sensitive indicator of lead effects. Ind Health 32: 85-96
23. 23. Pardridge WM (1998) Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 23: 635-644
24. 24. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143: 139-142
25. 25. Rick K, Sroka P, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R (1997) Pharmakokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B Biol 40: 313-319
26. 26. Salmon E, Raftopoulos C, Timmermans L (1981) First elements of comparison between blood-tissue barriers at cerebral, genital and urinary levels. CR Seances Soc Biol Fil 175: 259-265
27. 27. Song D, Wientjes MG, Au JL (1997) Bladder tissue pharmacokinetics of intravesical taxol. Cancer Chemother Pharmacol 40: 285-292
28. 28. Wientjes MG, Badalament RA, Au JL (1996) Penetration of intravesical doxorubicin in human bladders. Cancer Chemother Pharmacol 37: 539-546